Opus Genetics share price logo

Opus Genetics

NASDAQ: IRD

Small Cap

$3.82

-0.30

(-7.17%)

as on

Opus Genetics Stock Performance

as on October 23, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $3.80
    $4.10
    downward going graph

    0.52%

    Downside

    7.33%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.70
    $7.07
    downward going graph

    55.50%

    Downside

    85.08%

    Upside

    downward going graph

Opus Genetics share price movements today

Previous Close
$4.12
Open
$4.01
Volume
1.1M
Market Cap
$342.4M
Day's Low - High
$3.80 - $4.10
52 Week Low - High
$1.70 - $7.07

Opus Genetics Historical Returns

1 Month Return
-20.91 %
3 Month Return
+ 30.82 %
1 Year Return
+ 91 %
3 Year Return
0 %
5 Year Return
0 %

Opus Genetics Stock Fundamentals & Key Indicators

Check Opus Genetics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$342.4M

EPS (TTM)

-1.27

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.24

Industry PE ratio

-7.12

PEG Ratio

0.08

EBITDA

-104.9M

Revenue (TTM)

9.9M

Profit Margin

99.87%

Return On Equity TTM

1147.63%

Opus Genetics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Opus Genetics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Opus Genetics image
Opus Genetics
StrongBuy$342.4MNA-3.2499.87%0.00%
Moderna image
Moderna
Neutral$98.1B-37.95%-30.80-12.57%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$44.0BNA27.4787.82%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.9B191.61%30.2886.04%0.00%
Regeneron image
Regeneron
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Opus Genetics Stock including INR - Dollar returns

The Opus Genetics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Opus Genetics investment value today

Current value as on today

₹2,06,407

Returns

₹1,06,407

(+106.41%)

Returns from Opus Genetics Stock

₹91,000 (+91%)

Dollar Impact

₹15,407 (+15.41%)

Analyst Recommendation on Opus Genetics Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Opus Genetics. Average target price of $13.6

Opus Genetics Share Price Target

Get share price movements and forecasts by analysts on Opus Genetics.

Current Price

$3.82

Analyzed by

6 Analysts

High

$17

0

Low

$8

Opus Genetics target price $0, a slight upside of 0% compared to current price of $3.82. According to 6 analysts rating.

Indian Investors' Interest in Opus Genetics Stock

Investment in Opus Genetics Shares on INDmoney has grown by 947.36% in the last 30 days, indicating increased investment activity.

Time period: to

Change:947.36% versus previous 30 day period

Search interest for Opus Genetics Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-62% versus previous 30 day period

Opus Genetics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1
1
3
4
4
2
3
3
2
0
Gross Profit
1
1
3
-3
4
-3
3
3
2
0
Operating Income
-7
-8
-8
-38
-9
-8
-8
-11
-14
-16
EBITDA
-7
-7
-7
-10
-6
-7
-17
-15
-64
-7
Interest Expense
-
-
-
-
1
0
0
1
0
0
Depreciation
-
-
-
0
0
0
0
0
0
0
Income Before Tax
-7
-7
-7
-35
-8
-7
-17
-16
-65
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-7
-7
-7
-35
-8
-7
-17
-16
-65
-8
Net Profit Margin
100.00%
100.00%
100.00%
-80.80%
100.00%
-108.95%
100.00%
100.00%
99.40%
100.00%

Opus Genetics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
0
39
19
10
14
Gross Profit
-
-
0
39
19
10
14
Operating Income
-4
-19
-22
18
-10
-62
-38
EBITDA
-4
-17
-56
18
-9
-57
-48
Interest Expense
1
6
0
0
1
-
1
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-6
-24
-56
18
-9
-57
-49
Income Tax Expense
-
-
-
0
0
-
-
Net Income
-6
-24
-56
17
-9
-57
-49
Net Profit Margin
0.00%
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%

Opus Genetics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-7
-7
-7
-35
-8
-7
-17
-16
-65
-8
Operating Cash Flow
-5
-7
-5
-7
-8
-10
-6
-9
-12
-11
Investing Cash Flow
-
-
-
1
-
-
-
-
-
-
Financing Cash Flow
2
1
0
0
20
0
4
24
27
40
Change in Cash
-3
-5
-4
-6
11
-9
-1
14
14
28

Opus Genetics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-24
-56
17
-9
-57
-49
Operating Cash Flow
-3
-6
-19
14
-1
-25
-35
Investing Cash Flow
0
0
0
-
-
1
-
Financing Cash Flow
4
21
27
3
8
4
50
Change in Cash
1
14
8
18
7
-20
14

Global Institutional Holdings in Opus Genetics

Check out the Institutions with significant holdings in Opus Genetics.

Funds
Holdings
Vanguard
4.74%
iShares
3.12%
VANGUARD INDEX FUNDS
2.84%
Joseph Edelman
2.21%
Michael Rockefeller
1.72%
See all

Opus Genetics News & Key Events

  • img

    Today's Timeline - 21 October

    Wed, 04:36 PM

    -

    Opus Genetics receives FDA clearance for OPGx-RDH12 IND application, advancing gene therapy for a rare inherited retinal disease.

    Thu, 03:23 AM

    -

    Opus Genetics announces transition of Chief Scientific Officer Ashwath Jayagopal, effective October 19, 2026, with a consulting agreement.

Insights on Opus Genetics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, IRD stock has moved up by 30.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 580.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 125.1%

About Opus Genetics

Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
OrganisationOpus Genetics
Headquarters8 Davis Drive, Durham, NC, 27713, US
IndustryBiotechnology
CEOGeorge Magrath

Key Management of Opus Genetics

Name

Title

Mr. Joseph K. Schachle MBA

Chief Operating Officer

Dr. Ashwath Jayagopal M.B.A., Ph.D.

Chief Scientific & Development Officer

Mr. Robert E. Gagnon CPA, M.B.A.

CFO & Principal Accounting Officer

Ms. Amy Zaremba Rabourn C.P.A., MAcc

Head of Financial Quality Assurance

Ms. Bindu Manne

Head of Market Development & Commercialization

Dr. George Magrath M.B.A., M.D., M.S.

CEO & Director

Dr. Benjamin R. Yerxa Ph.D.

President & Director

Mr. Bernhard Hoffmann M.B.A.

Senior Vice President of Corporate Development & Secretary

Mr. Chris Ernst

Chief Technology Officer

Ms. Jenny Kobin

Investor Relations Officer

FAQs

What is Opus Genetics share price today?

Opus Genetics share price today is $3.82 as on at the close of the market. Opus Genetics share today touched a day high of $4.10 and a low of $3.80.

What is the 52 week high and 52 week low for Opus Genetics share?

Opus Genetics share touched a 52 week high of $7.07 on and a 52 week low of $1.70 on . Opus Genetics stock price today i.e. is closed at $3.82,which is 45.97% down from its 52 week high and 124.71% up from its 52 week low.

What is Opus Genetics's market capitalisation today?

Opus Genetics market capitalisation is $0.00T as on .

How to invest in Opus Genetics Stock (IRD) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Opus Genetics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Opus Genetics Stock (IRD) from India?

Indian investors can start investing in Opus Genetics (IRD) shares with as little as ₹94.81749725341797 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.17 in Opus Genetics stock (as per the Rupee-Dollar exchange rate as on ). Based on Opus Genetics share’s latest price of $3.82 as on October 23, 2026 at 8:45 am IST, you will get 2.6178 shares of Opus Genetics. Learn more about fractional shares .